Viatris (VTRS) EBITDA (2020 - 2026)
Viatris (VTRS) reported EBITDA of $678.6 million for Q2 2026, down 25.5% from $911.3 million a year earlier but up 13.8% from the prior quarter.
Powered by 
Analysis
Viatris (VTRS) EBITDA (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Viatris' EBITDA came in at $2.72 billion; for FY2025, it came in at $135.2 million, down 95.3% from FY2024.
- EBITDA has declined for three consecutive years, with a five-year compound annual growth rate of -41.7% (FY2020 to FY2025).
- By year, EBITDA came in at $2.9 billion in FY2024 (-17.2%), $3.51 billion in FY2023 (-24.5%), $4.64 billion in FY2022 (+3.8%) and $4.47 billion in FY2021 (+123.0%).
- Five-year quarterly EBITDA spans a low of -$2.22 billion in Q1 2025 and a high of $1.44 billion in Q1 2022.
- Year over year, EBITDA gained in three of the last six quarters, with growth averaging 36.1%.
- The high point for year-over-year EBITDA in five years was Q4 2021 (growth of 833.6%); the low point was Q4 2023 (a decline of 71.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $596.4 million (Q1 2026), $574.1 million (Q4 2025) and $867.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Viatris | 20.35 Bn | 15.36 Bn | 1.46 Bn | 678.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 678.60 Mn |
| Mar 31, 2026 | 596.40 Mn |
| Dec 31, 2025 | 574.10 Mn |
| Sep 30, 2025 | 867.30 Mn |
| Jun 30, 2025 | 911.30 Mn |
| Mar 31, 2025 | -2.22 Bn |
| Dec 31, 2024 | 566.40 Mn |
| Sep 30, 2024 | 895.60 Mn |
| Jun 30, 2024 | 546.40 Mn |
| Mar 31, 2024 | 894.90 Mn |
| Dec 31, 2023 | 189.90 Mn |
| Sep 30, 2023 | 1.13 Bn |
| Jun 30, 2023 | 1.06 Bn |
| Mar 31, 2023 | 1.13 Bn |
| Dec 31, 2022 | 668.50 Mn |
| Sep 30, 2022 | 1.26 Bn |
| Jun 30, 2022 | 1.27 Bn |
| Mar 31, 2022 | 1.44 Bn |
| Dec 31, 2021 | 672.20 Mn |
| Sep 30, 2021 | 1.37 Bn |
API Access
Viatris EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=VTRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "VTRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=VTRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();